Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 4:01 pm Purchase | 2026-06-30 | 13G | IDEAYA BIOSCIENCES INC IDYA | Baker Bros. Advisors LP | 5,010,030 5.200% | 5,010,030 (New Position) | Filing History |
| 2026-08-14 4:01 pm Purchase | 2026-06-30 | 13G | REVOLUTION MEDICINES INC RVMD | Baker Bros. Advisors LP | 11,443,357 5.300% | 1,988,000 (+21.03%) | Filing History |
| 2026-08-14 4:00 pm Sale | 2026-06-30 | 13G | IMMATICS N V IMTX | Baker Bros. Advisors LP | 9,508,565 7.000% | -2,585,529 (-21.38%) | Filing History |
| 2026-08-14 4:00 pm Sale | 2026-06-30 | 13G | EDGEWISE THERAPEUTICS INC EWTX | Baker Bros. Advisors LP | 3,701,719 3.400% | -3,604,221 (-49.33%) | Filing History |
| 2026-08-14 4:00 pm Sale | 2026-06-30 | 13G | CERUS CORP CERS | Baker Bros. Advisors LP | 6,415,295 3.200% | -3,612,914 (-36.03%) | Filing History |
| 2026-08-11 5:50 pm Purchase | 2026-08-09 | 13D | REPLIMUNE GROUP INC REPL | Baker Bros. Advisors LP | 11,075,336 11.800% | 30,000 (+0.27%) | Filing History |
| 2026-07-16 5:57 pm Unchanged | 2026-07-14 | 13G | CELCUITY INC CELC | Baker Bros. Advisors LP | 4,877,963 9.990% | 0 (Unchanged) | Filing History |
| 2026-07-16 5:51 pm Sale | 2026-07-14 | 13D | CELCUITY INC CELC | Baker Bros. Advisors LP | 4,877,963 9.990% | -4,704,911 (-49.10%) | Filing History |
| 2026-06-15 4:40 pm Sale | 2026-06-11 | 13D | BEONE MEDICINES LTD. AMERICAN ONC | Baker Bros. Advisors LP | 115,912,814 8.000% | -5,499 (-0.00%) | Filing History |
| 2026-05-26 5:04 pm Purchase | 2026-05-21 | 13D | KINIKSA PHARMACEUTICALS INTL P KNSA | Baker Bros. Advisors LP | 3,253,341 7.000% | 102,312 (+3.25%) | Filing History |
| 2026-05-15 4:18 pm Purchase | 2026-03-31 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | Baker Bros. Advisors LP | 8,876,346 9.990% | 4,530,610 (+104.25%) | Filing History |
| 2026-05-15 4:17 pm Purchase | 2026-03-31 | 13G | GRAIL INC GRAL | Baker Bros. Advisors LP | 4,028,614 9.800% | 1,943,281 (+93.19%) | Filing History |
| 2026-05-15 4:17 pm Sale | 2026-03-31 | 13G | KALA BIO, INC PAR $ KALA | Baker Bros. Advisors LP | 2,312 0.010% | -2,887,743 (-99.92%) | Filing History |
| 2026-05-15 4:17 pm Purchase | 2026-03-31 | 13G | PRAXIS PRECISION MEDICINES INC PRAX | Baker Bros. Advisors LP | 1,753,198 6.300% | 1,753,198 (New Position) | Filing History |
| 2026-05-11 4:59 pm Purchase | 2026-05-07 | 13D | INCYTE CORPORATION INCY | Baker Bros. Advisors LP | 31,225,572 15.600% | 12,155 (+0.04%) | Filing History |
| 2026-05-07 4:10 pm Purchase | 2026-04-30 | 13G | ABCELLERA BIOLOGICS INC. ABCL | Baker Bros. Advisors LP | 33,012,138 10.800% | 5,486,498 (+19.93%) | Filing History |
| 2026-04-22 4:22 pm Purchase | 2026-04-20 | 13D | PRELUDE THERAPEUTICS INC PRLD | Baker Bros. Advisors LP | 10,295,301 15.500% | 25,333 (+0.25%) | Filing History |
| 2026-04-16 4:32 pm Sale | 2026-04-16 | 13D | BEONE MEDICINES LTD. AMERICAN ONC | Baker Bros. Advisors LP | 115,918,313 8.000% | -9,358,297 (-7.47%) | Filing History |
| 2026-03-24 4:06 pm Purchase | 2026-03-20 | 13D | CELCUITY INC CELC | Baker Bros. Advisors LP | 9,582,874 19.990% | 1,837,182 (+23.72%) | Filing History |
| 2026-02-26 6:59 pm Purchase | 2026-02-24 | 13D | ACADIA PHARMACEUTICALS INC ACAD | Baker Bros. Advisors LP | 43,294,373 25.400% | 66,774 (+0.15%) | Filing History |